Birch Pollen Allergy Immunotherapy
The site focuses on immune system diseases and conducts trials for patients with moderate‑to‑severe allergic rhinitis triggered by birch pollen, aiming to evaluate new immunotherapy approaches.
- Subcutaneous cluster‑immunotherapy
- Sublingual tablet immunotherapy
- Benefit‑risk balance assessment
- Combined Symptom and Medication Score as primary outcome
HNO-Praxis Dr. med. Udo Schäfer in Dresden collaborates with international partners to improve symptom control and medication use for birch pollen allergy sufferers.
House Dust Mite Allergy Research
Clinical work at the practice includes studies on allergic rhinitis caused by house dust mites, targeting patients with persistent moderate‑to‑severe symptoms and seeking safer, effective treatments.
- Sublingual immunotherapy for house dust mite allergy
- Evaluation of long‑term safety
- Optimization of dosing schedules
- Use of the Combined Symptom and Medication Score to measure benefit
The Dresden clinic provides a specialized environment for allergy patients, contributing valuable data to global efforts in managing dust mite–induced respiratory disease.
Dose Optimization in Allergy Treatment
Across its trials, the centre investigates the most effective and well‑tolerated doses of emerging therapies for allergic rhinitis, balancing efficacy with safety.
- Determination of optimal dose levels
- Assessment of tolerability across patient groups
- Comparison of subcutaneous versus sublingual routes
- Application of the Combined Symptom and Medication Score for benefit‑risk analysis
By enrolling patients with birch pollen and house dust mite sensitivities, HNO-Praxis Dr. med. Udo Schäfer advances personalized allergy care in Europe.
